"Immunization, Secondary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Any immunization following a primary immunization and involving exposure to the same or a closely related antigen.
Descriptor ID |
D007117
|
MeSH Number(s) |
E02.095.465.425.400.485 E05.478.550.550
|
Concept/Terms |
Immunization, Secondary- Immunization, Secondary
- Immunizations, Secondary
- Secondary Immunizations
- Immunization, Booster
- Booster Immunization
- Booster Immunizations
- Immunizations, Booster
- Secondary Immunization
|
Below are MeSH descriptors whose meaning is more general than "Immunization, Secondary".
Below are MeSH descriptors whose meaning is more specific than "Immunization, Secondary".
This graph shows the total number of publications written about "Immunization, Secondary" by people in this website by year, and whether "Immunization, Secondary" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 0 | 1 | 1 |
1995 | 2 | 0 | 2 |
1996 | 0 | 2 | 2 |
1997 | 1 | 1 | 2 |
1998 | 0 | 2 | 2 |
1999 | 0 | 3 | 3 |
2000 | 1 | 0 | 1 |
2002 | 0 | 1 | 1 |
2004 | 1 | 1 | 2 |
2005 | 0 | 4 | 4 |
2006 | 0 | 2 | 2 |
2007 | 0 | 2 | 2 |
2008 | 0 | 2 | 2 |
2009 | 2 | 2 | 4 |
2010 | 3 | 3 | 6 |
2011 | 0 | 1 | 1 |
2013 | 1 | 1 | 2 |
2014 | 1 | 1 | 2 |
2015 | 2 | 1 | 3 |
2016 | 1 | 1 | 2 |
2017 | 0 | 1 | 1 |
2019 | 1 | 2 | 3 |
2021 | 1 | 3 | 4 |
2022 | 1 | 4 | 5 |
2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Immunization, Secondary" by people in Profiles.
-
Investigation of the frequencies of various B cell populations in non-responder healthcare workers in comparison with responders to hepatitis B virus vaccination. Trans R Soc Trop Med Hyg. 2023 09 01; 117(9):628-636.
-
Antibody evasion by SARS-CoV-2 Omicron subvariants BA.2.12.1, BA.4 and BA.5. Nature. 2022 08; 608(7923):603-608.
-
A Randomized Dose-Escalating Phase I Trial of a Replication-Deficient Lymphocytic Choriomeningitis Virus Vector-Based Vaccine Against Human Cytomegalovirus. J Infect Dis. 2022 04 19; 225(8):1399-1410.
-
Effectiveness of a Third Dose of Pfizer-BioNTech and Moderna Vaccines in Preventing COVID-19 Hospitalization Among Immunocompetent and Immunocompromised Adults - United States, August-December 2021. MMWR Morb Mortal Wkly Rep. 2022 Jan 28; 71(4):118-124.
-
Homologous and Heterologous Covid-19 Booster Vaccinations. N Engl J Med. 2022 03 17; 386(11):1046-1057.
-
Effectiveness of BNT162b2 Vaccine against Critical Covid-19 in Adolescents. N Engl J Med. 2022 02 24; 386(8):713-723.
-
Factors affecting antibody responses to immunizations in infants born to women immunized against pertussis in pregnancy and unimmunized women: Individual-Participant Data Meta-analysis. Vaccine. 2021 10 22; 39(44):6545-6552.
-
Efficacy of the mRNA-1273 SARS-CoV-2 Vaccine at Completion of Blinded Phase. N Engl J Med. 2021 Nov 04; 385(19):1774-1785.
-
The effect of BCG revaccination on all-cause mortality beyond infancy: 30-year follow-up of a population-based, double-blind, randomised placebo-controlled trial in Malawi. Lancet Infect Dis. 2021 11; 21(11):1590-1597.
-
Sleeping Beauty and Hepatitis B: An Evidence-Based Guide for Dermatologists. Skinmed. 2021; 19(1):37-41.